Though mirror biology might lead to improved drugs and other innovations, scientists have warned against potentially devastating consequences of this research
Category: innovation
Nearly Half of US Unicorn Founders Were Born Outside the US. Immigrants are crucial for US innovation: our research revealed that 65 countries (apart from the US) have produced at least one founder…
Immigrants are crucial for US innovation: our research revealed that 65 countries (apart from the US) have produced at least one founder of a US unicorn. Here is the list of countries with 10 or more US unicorn founders by continent:
• Europe: The United Kingdom leads with 31 founders, followed by Germany (18), France (17), Russia (14), Ukraine (12), and Ireland (10).
• Asia: India leads with 90 founders, followed by Israel (52), China (27), and Taiwan (12).
Building capacity to beat cancer with a targeted radiopharmaceutical
The suite of powerful particle accelerators at RIKEN has a long history of dual-purpose use. As well as the central role these instruments play in fundamental nuclear physics research, they have also long been employed in the production of valuable radioisotopes.
Today, some of the strongest radioisotope demand comes from medicine, where they are used in imaging and increasingly, as cancer treatments. Currently, there is a rapidly growing interest in astatine-211, a promising radioisotope for the potential selective treatment of numerous cancers.
Fortunately, innovative new methods for producing astatine-211 in practical amounts have recently been pioneered at our facility. And, a recently launched human clinical trial at Osaka University Hospital of an astatine-211 based anticancer radiopharmaceutical, a first for Japan, is leveraging these new production abilities. (Circa 2024)
RIKEN’s particle accelerator facilities are producing astatine-211, a radioisotope with great promise for selective anti-tumor therapies, says Hiromitsu Haba.
Huge US Chip Breakthrough — and a Big Warning For All
Anastasi In Tech
